Kamada Ltd. - Report Publication Announcement 2021

Kamada Enters into Two New Agreements for the Distribution of Three Biosimilar Products in Israel false


	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	13/01/2021
	www.isa.gov.il			www.tase.co.il				Reference:	2021-02-005859	Time of broadcast: 13:53 13:53

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onKamada Enters into Two New Agreements for the Distribution of Three Biosimilar Products in Israel

ea133044-6k_kamadaltdEDGAR5_Bannerless_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: TASE	Date of revision of form structure: 31/12/2020
Address: Holtzman 2 4081 , Rehovot 7670402 ISRAEL , Tel: 08-9406472 , Fax: 08-9406473
E-mail address: [email protected] Company site: www.kamada.com

Previous names of reporting entity:

Name of the Signatory: Fhima Lior Position of Signatory in the reporting corporation: Director of Finance Name of Employer Company:
Address: Haim holtzman 2 , Rehovot 7670402 Telephone: 08-9913168 Facsimile: 08-9912083 E-mail: [email protected] 1

AI assistant